Literature DB >> 20547024

The aqueous stability of bupropion.

Paul M O'Byrne1, Robert Williams, John J Walsh, John F Gilmer.   

Abstract

In this study the aqueous stability of bupropion was determined and the pH-degradation profile was obtained. The effects of hydrogen ion, solvent and hydroxide ion concentration are discussed with particular emphasis on the kinetics of degradation of bupropion. Kinetics and degradation of bupropion were determined by HPLC-UV and LC-MS analysis both utilising high pH chromatographic methods. Degradation of bupropion in aqueous solutions follows first-order reaction kinetics. The pH-degradation profile was determined using non-linear regression analysis. The micro- and macro-reaction constants for degradation are presented. Bupropion was most stable in aqueous solutions below pH 5. Degradation was catalyzed by water but mainly by hydroxide ion on the unionised form of bupropion. The energy of activation for decomposition in aqueous solution pH 10.7 I=0.055 was determined to be 53 kJ mol(-1) with a frequency factor of 6.43 x 10(10)s(-1). The degradants of bupropion were positively identified and a mechanism of degradation is proposed. The inherent instability of bupropion above pH 5 has implications for its therapeutic use, formulation, pharmacokinetics and use during analysis and storage. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20547024     DOI: 10.1016/j.jpba.2010.04.024

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  5 in total

1.  Biodegradation of Ephedrine Isomers by Arthrobacter sp. Strain TS-15: Discovery of Novel Ephedrine and Pseudoephedrine Dehydrogenases.

Authors:  Tarek Shanati; Marion B Ansorge-Schumacher
Journal:  Appl Environ Microbiol       Date:  2020-03-02       Impact factor: 4.792

2.  Population model analysis of chiral inversion and degradation of bupropion enantiomers, and application to enantiomer specific fraction unbound determination in rat plasma and brain.

Authors:  Chandrali Bhattacharya; Andrea R Masters; Christine Bach; Robert E Stratford
Journal:  J Pharm Biomed Anal       Date:  2020-12-26       Impact factor: 3.935

3.  Synthesis, screening and pharmacokinetic evaluation of potential prodrugs of bupropion. Part one: in vitro development.

Authors:  Paul Matthew O'Byrne; Robert Williams; John J Walsh; John F Gilmer
Journal:  Pharmaceuticals (Basel)       Date:  2014-05-14

4.  Part Two: Evaluation of N-methylbupropion as a Potential Bupropion Prodrug.

Authors:  Paul Matthew O'Byrne; Robert Williams; John J Walsh; John F Gilmer
Journal:  Pharmaceuticals (Basel)       Date:  2014-05-28

5.  The effect of polysorbate 20 on solubility and stability of candesartan cilexetil in dissolution media.

Authors:  Katarzyna Hoppe; Małgorzata Sznitowska
Journal:  AAPS PharmSciTech       Date:  2014-05-29       Impact factor: 3.246

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.